Research Repository

Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-κB activation

Zwacka, RM and Zhou, W and Zhang, Y and Darby, CJ and Dudus, L and Halldorson, J and Oberley, L and Engelhardt, JF (1998) 'Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-κB activation.' Nature Medicine, 4 (6). 698 - 704. ISSN 1078-8956

Full text not available from this repository.


Liver transplantation is the only therapeutic strategy for many inherited and acquired diseases. The formation of reactive oxygen species following ischemia/reperfusion is a cause of hepatocellular injury during transplantation. This report describes the therapeutic application of mitochondrial superoxide dismutase gene transfer to the liver for acute ischemia/reperfusion injury. Recombinant adenoviral expression of mitochondrial superoxide dismutase in mouse liver prior to lobar ischemia/reperfusion significantly reduced acute liver damage and associated redox activation of both NF-κB and AP1. These immediate early transcription factors represent common pathways by which cells respond to environmental stress. This work provides the foundation for redox-mediated gene therapies directed at ameliorating ischemia/reperfusion injury and associated acute rejection in orthotopic liver transplantation.

Item Type: Article
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Faculty of Science and Health > Life Sciences, School of
Depositing User: Jim Jamieson
Date Deposited: 12 Jul 2017 16:14
Last Modified: 16 Sep 2019 17:16

Actions (login required)

View Item View Item